RXRX
Price
$4.38
Change
+$0.19 (+4.53%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.7B
96 days until earnings call
TPST
Price
$6.79
Change
+$0.37 (+5.76%)
Updated
May 8, 04:54 PM (EDT)
Capitalization
25.04M
Earnings call today
Ad is loading...

RXRX vs TPST

Header iconRXRX vs TPST Comparison
Open Charts RXRX vs TPSTBanner chart's image
Recursion Pharmaceuticals
Price$4.38
Change+$0.19 (+4.53%)
Volume$159.95K
Capitalization1.7B
Tempest Therapeutics
Price$6.79
Change+$0.37 (+5.76%)
Volume$100
Capitalization25.04M
RXRX vs TPST Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXRX vs. TPST commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Hold and TPST is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (RXRX: $4.19 vs. TPST: $6.42)
Brand notoriety: RXRX and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 107% vs. TPST: 67%
Market capitalization -- RXRX: $1.7B vs. TPST: $25.04M
RXRX [@Biotechnology] is valued at $1.7B. TPST’s [@Biotechnology] market capitalization is $25.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • RXRX’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both RXRX and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 3 TA indicator(s) are bullish while TPST’s TA Score has 5 bullish TA indicator(s).

  • RXRX’s TA Score: 3 bullish, 5 bearish.
  • TPST’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TPST is a better buy in the short-term than RXRX.

Price Growth

RXRX (@Biotechnology) experienced а -25.04% price change this week, while TPST (@Biotechnology) price change was -9.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

RXRX is expected to report earnings on Aug 12, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.7B) has a higher market cap than TPST($25M). RXRX YTD gains are higher at: -38.018 vs. TPST (-40.821). TPST has higher annual earnings (EBITDA): -40.14M vs. RXRX (-426.72M). TPST has less debt than RXRX: TPST (15.4M) vs RXRX (108M). RXRX has higher revenues than TPST: RXRX (58.5M) vs TPST (0).
RXRXTPSTRXRX / TPST
Capitalization1.7B25M6,812%
EBITDA-426.72M-40.14M1,063%
Gain YTD-38.018-40.82193%
P/E RatioN/AN/A-
Revenue58.5M0-
Total Cash594MN/A-
Total Debt108M15.4M701%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXTPST
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVUX16.700.06
+0.36%
MFS New Discovery Value R4
DNSMX19.860.07
+0.35%
Driehaus Small Cap Growth Institutional
HACAX106.90N/A
N/A
Harbor Capital Appreciation Instl
FMKFX19.55N/A
N/A
Fidelity Magellan K6
BMPEX24.53-0.02
-0.08%
Beck Mack + Oliver Partners

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-3.75%
PHIO - TPST
49%
Loosely correlated
+18.60%
ABCZF - TPST
48%
Loosely correlated
N/A
RXRX - TPST
38%
Loosely correlated
+0.84%
VERV - TPST
36%
Loosely correlated
-3.21%
IMNM - TPST
36%
Loosely correlated
-2.56%
More